Lynnie Trzoss

Person

San Diego, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Pyridinone MK2 inhibitors and uses thereof
- Patent number 12,139,462
- Issue date Nov 12, 2024
- XinThera, Inc.
- Robert L. Hoffman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
MK2 inhibitors and uses thereof
- Patent number 11,987,574
- Issue date May 21, 2024
- XinThera, Inc.
- Lynnie Trzoss
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic compounds
- Patent number 11,890,275
- Issue date Feb 6, 2024
- Celgene Quanticel Research, Inc.
- Lynnie Trzoss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Azetidine and pyrrolidine PARP1 inhibitors and uses thereof
- Patent number 11,802,128
- Issue date Oct 31, 2023
- XINTHERA, INC.
- Robert L. Hoffman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chemical compounds as inhibitors of interleukin-1 activity
- Patent number 11,702,428
- Issue date Jul 18, 2023
- Genentech, Inc.
- Jeffrey A. Stafford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyridinone MK2 inhibitors and uses thereof
- Patent number 11,685,719
- Issue date Jun 27, 2023
- XINTHERA, INC.
- Robert L. Hoffman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
MK2 inhibitors and uses thereof
- Patent number 11,680,056
- Issue date Jun 20, 2023
- XINTHERA, INC.
- Lynnie Trzoss
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
PARP1 inhibitors and uses thereof
- Patent number 11,591,331
- Issue date Feb 28, 2023
- XINTHERA, INC.
- Lynnie Trzoss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sulfonylurea compounds as inhibitors of interleukin-1 activity
- Patent number 11,560,391
- Issue date Jan 24, 2023
- Genentech, Inc.
- Jeffrey A. Stafford
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chemical compounds as inhibitors of interleukin-1 activity
- Patent number 11,040,985
- Issue date Jun 22, 2021
- Genentech, Inc.
- Jeffrey A. Stafford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic compounds
- Patent number 11,020,380
- Issue date Jun 1, 2021
- Celgene Quanticel Research, Inc.
- Lynnie Trzoss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic compounds
- Patent number 10,617,680
- Issue date Apr 14, 2020
- Celgene Quanticel Research, Inc.
- Lynnie Trzoss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Seriniquinones, melanoma-specific anticancer agents
- Patent number 9,481,662
- Issue date Nov 1, 2016
- The Regents of the University of California
- William Fenical
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Therapeutic Compounds
- Publication number 20240293381
- Publication date Sep 5, 2024
- Celgene Quanticel Research, Inc.
- Lynnie TRZOSS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIDINONE MK2 INHIBITORS AND USES THEREOF
- Publication number 20230382864
- Publication date Nov 30, 2023
- Xinthera, Inc.
- Robert L. HOFFMAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MK2 INHIBITORS AND USES THEREOF
- Publication number 20230373969
- Publication date Nov 23, 2023
- Xinthera, Inc.
- Lynnie TRZOSS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MK2 INHIBITORS AND USES THEREOF
- Publication number 20230265076
- Publication date Aug 24, 2023
- Xinthera, Inc.
- Lynnie TRZOSS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AZETIDINE AND PYRROLIDINE PARP1 INHIBITORS AND USES THEREOF
- Publication number 20230203033
- Publication date Jun 29, 2023
- Xinthera, Inc.
- Robert L. HOFFMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AZETIDINE AND PYRROLIDINE PARP1 INHIBITORS AND USES THEREOF
- Publication number 20230159525
- Publication date May 25, 2023
- Xinthera, Inc.
- Robert L. HOFFMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PARP1 INHIBITORS AND USES THEREOF
- Publication number 20230128041
- Publication date Apr 27, 2023
- Xinthera, Inc.
- Lynnie TRZOSS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIDINONE MK2 INHIBITORS AND USES THEREOF
- Publication number 20230053465
- Publication date Feb 23, 2023
- Xinthera, Inc.
- Robert L. HOFFMAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MK2 INHIBITORS AND USES THEREOF
- Publication number 20220402892
- Publication date Dec 22, 2022
- Xinthera, Inc.
- Lynnie TRZOSS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PARP1 INHIBITORS AND USES THEREOF
- Publication number 20220348574
- Publication date Nov 3, 2022
- Xinthera, Inc.
- Lynnie TRZOSS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHEMICAL COMPOUNDS AS INHIBITORS OF INTERLEUKIN-1 ACTIVITY
- Publication number 20220306649
- Publication date Sep 29, 2022
- Genentech, Inc.
- Jeffrey A. STAFFORD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHEMICAL COMPOUNDS AS INHIBITORS OF INTERLEUKIN-1 ACTIVITY
- Publication number 20210395268
- Publication date Dec 23, 2021
- Genentech, Inc.
- Jeffrey A. STAFFORD
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SULFONYLUREA COMPOUNDS AS INHIBITORS OF INTERLEUKIN-1 ACTIVITY
- Publication number 20210261568
- Publication date Aug 26, 2021
- Genentech, Inc.
- Jeffrey A. STAFFORD
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SULFONIMIDAMIDE COMPOUNDS AS INHIBITORS OF INTERLEUKIN-1 ACTIVITY
- Publication number 20210253596
- Publication date Aug 19, 2021
- Genentech, Inc.
- Christopher MCBRIDE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC COMPOUNDS
- Publication number 20210205284
- Publication date Jul 8, 2021
- Celgene Quanticel Research, Inc.
- Lynnie TRZOSS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC COMPOUNDS
- Publication number 20200163946
- Publication date May 28, 2020
- Celgene Quanticel Research, Inc.
- Lynnie TRZOSS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHEMICAL COMPOUNDS AS INHIBITORS OF INTERLEUKIN-1 ACTIVITY
- Publication number 20190337965
- Publication date Nov 7, 2019
- Genentech, Inc.
- Jeffrey A. STAFFORD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC COMPOUNDS
- Publication number 20180296543
- Publication date Oct 18, 2018
- Celgene Quanticel Research, Inc.
- Lynnie TRZOSS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SERINIQUINONES, MELANOMA-SPECIFIC ANTICANCER AGENTS
- Publication number 20150148314
- Publication date May 28, 2015
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, a California Corporation
- William Fenical
- C07 - ORGANIC CHEMISTRY

Lynnie Trzoss

Person

Patents Grantslast 30 patents

Pyridinone MK2 inhibitors and uses thereof

MK2 inhibitors and uses thereof

Therapeutic compounds

Azetidine and pyrrolidine PARP1 inhibitors and uses thereof

Chemical compounds as inhibitors of interleukin-1 activity

Pyridinone MK2 inhibitors and uses thereof

MK2 inhibitors and uses thereof

PARP1 inhibitors and uses thereof

Sulfonylurea compounds as inhibitors of interleukin-1 activity

Chemical compounds as inhibitors of interleukin-1 activity

Therapeutic compounds

Therapeutic compounds

Seriniquinones, melanoma-specific anticancer agents

Patents Applicationslast 30 patents

Therapeutic Compounds

PYRIDINONE MK2 INHIBITORS AND USES THEREOF

MK2 INHIBITORS AND USES THEREOF

MK2 INHIBITORS AND USES THEREOF

AZETIDINE AND PYRROLIDINE PARP1 INHIBITORS AND USES THEREOF

AZETIDINE AND PYRROLIDINE PARP1 INHIBITORS AND USES THEREOF

PARP1 INHIBITORS AND USES THEREOF

PYRIDINONE MK2 INHIBITORS AND USES THEREOF

MK2 INHIBITORS AND USES THEREOF

PARP1 INHIBITORS AND USES THEREOF

CHEMICAL COMPOUNDS AS INHIBITORS OF INTERLEUKIN-1 ACTIVITY

CHEMICAL COMPOUNDS AS INHIBITORS OF INTERLEUKIN-1 ACTIVITY

SULFONYLUREA COMPOUNDS AS INHIBITORS OF INTERLEUKIN-1 ACTIVITY

SULFONIMIDAMIDE COMPOUNDS AS INHIBITORS OF INTERLEUKIN-1 ACTIVITY

THERAPEUTIC COMPOUNDS

THERAPEUTIC COMPOUNDS

CHEMICAL COMPOUNDS AS INHIBITORS OF INTERLEUKIN-1 ACTIVITY

THERAPEUTIC COMPOUNDS

SERINIQUINONES, MELANOMA-SPECIFIC ANTICANCER AGENTS